Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,826–3,850 of 27,380 studies, newest first · page 154 of 1096.

July 2025 25

  1. 2025-07-01

    Association of midlife hearing impairment and hearing aid use with incident dementia: analysis of two UK-based longitudinal cohort studies

    ✓ Peer-reviewed Risk factors Nature aging

    Key finding: We found modest associations and population attributable fractions for reported and measured 'midlife' hearing impairment, highlighting the need to consider age at measurement of risk factors in studies that target dementia prevention.

  2. 2025-07 month only

    Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

    ✓ Peer-reviewed Treatments Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Gantenerumab significantly reduced PiB-PET uptake overall and in most regions and showed no changes in FDG-PET or MRI measures. +4 more findings

  3. 2025-07 month only

    Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Three genome-wide significant associations were identified for p-tau181: TUBAP/rs76523946, P = 2.21E-08; CTNND2/rs142510573, P = 3.04E-08; CLSTN2/rs112448655, P = 3.04E-08, and one for t-tau (JHY/rs77264104, P = 2.84E-08). +4 more findings

  4. 2025-07 month only

    Focused ultrasound-mediated APOE4 knockdown in mouse brain

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: FUS-enhanced delivery of AAV resulted in a 12.6% knockdown of APOE ε4 gene expression in the targeted hippocampus, accompanied by an over 20% decrease in apoE4 protein levels and significant reductions in astrocyte and microglia levels. +4 more findings

  5. 2025-07 month only

    Smartphone Keystroke-based Cognitive Impairment Diagnostic Methodology

    ✓ Peer-reviewed Cognitive tests and assessment Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

    Key finding: Significant efforts are being made to address the health and other problems associated with dementia. +3 more findings

  6. 2025-07 month only

    Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Both Mann-Whitney tests and ANCOVA found significant differences between groups racialized as AA or NWH with respect to global 11[C]-Pittsburgh Compound B (PiB) standardized uptake value ratio (SUVR), cortical thickness values, p-tau181, and p-tau231 values (p < 0.05). +2 more findings

  7. 2025-07 month only

    Plasma p-tau231 in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional and longitudinal cohort study

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: E280A carriers had higher p-tau231 levels than non-carriers (9.0 ± 7.4 vs. 5.2 ± 3.4 pg/mL, P < 0.001). +4 more findings

  8. 2025-07 month only

    Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Relative to cybrids expressing mtDNA from CH individuals, MCI and AD cybrids contained more phosphorylated tau-217 (p-tau217), p-tau181, and total tau. +4 more findings

  9. 2025-07-01

    [Speech therapy after memory consultation: characteristics of patients receiving speech therapy sessions]

    ✓ Peer-reviewed Health systems and care delivery Geriatrie et psychologie neuropsychiatrie du vieillissement

    Key finding: Univariate analyses showed that speech therapy was more frequent in men, in patients with higher or secondary education, in patients suffering from Alzheimer's disease (AD) and having a higher MMSE. +3 more findings

  10. 2025-07-01

    Plasma placental growth factor as a biomarker for subcortical ischemic vascular dementia and its cognitive correlation mediated by white matter hyperintensities

    ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia

    Key finding: The plasma PlGF level was significantly elevated in patients with SIVD compared with CUCs, and showed a high accuracy with an area under the curve of 0.893. +4 more findings

  11. 2025-07-01

    Advance care planning and goals of care discussions with patients living with dementia

    ✓ Peer-reviewed End-of-life care Canadian Family Physician

    Key finding: How should I approach advance care planning (ACP) and goals of care (GOC) discussions with patients living with dementia? +2 more findings

  12. 2025-07-01
  13. 2025-07-01

    Seeing the trees in the wood: the importance of co-pathologies in Alzheimer’s disease and dementia with Lewy bodies

    ✓ Peer-reviewed Clinical safety Brain

    Key finding: In contrast, patients with LB pathology alone, in the absence of AD biomarker positivity, had less overall cognitive impairment but more focal dysexecutive and visuospatial deficits. +4 more findings

  14. 2025-07-01

    Utilization Patterns and Clinical Factors Associated With Hospitalization in Early‐Stage Dementia With Lewy Bodies

    ✓ Peer-reviewed Clinical safety International Journal of Geriatric Psychiatry

    Key finding: Patients with DLB had significantly greater rates of hospitalization and ED visits compared to patients with AD (Incidence Rate Ratio (IRR): 1.46, 95% CI 1.24, 1.73, IRR: 1.46, 95% CI 1.29, 1.77, respectively) and controls (IRR: 1.77, 95% CI 1.46, 2.14, IRR: 2.21, 95% CI 1.82, 2.69, respectively) and ED visits compared to those with VD (IRR: 1.24, 95% CI 1.03, 1.50). +4 more findings

  15. 2025-07-01

    Mechanisms of vitamin d deficiency as a risk factor for post-stroke depression, dementia, delirium, and fatigue: A promising therapeutic modality

    ✓ Peer-reviewed Clinical safety Journal of Affective Disorders Reports

    Key finding: Acute ischemic stroke often results in a multitude of neuropsychiatric complications, including depression, dementia, delirium, and fatigue. +2 more findings

  16. 2025-07-01

    Occurrence, associated factors, and outcomes of delirium in patients in an adult acute general medicine service in England: a 10-year longitudinal, observational study

    ✓ Peer-reviewed Clinical safety The Lancet Healthy Longevity

    Key finding: In those aged 65 years or older, delirium was overall associated (all p<0·001, age and sex adjusted) with dementia ( adj OR 3·63 [95% CI 2·65–4·98]), pre-admission dependency (2·63 [2·02–3·43]), comorbidity burden (1·04 [1·02–1·05]), and frailty (moderate vs low risk 3·62 [2·70–4·85] and high vs low risk 11·85 [7·24–19·42]), with stronger associations in patients without comorbid dementia than in those with comorbid dementia. +3 more findings

  17. 2025-07-01
  18. 2025-07-01

    Effect of combined transcranial direct current stimulation and cognitive training on brain microstructure and network homogeneity in late-life depression: a pilot study

    ✓ Peer-reviewed Prevention trials Journal of Affective Disorders Reports

    Key finding: Cognitive training, whether combined with active or sham tDCS, led to significantly increased fractional anisotropy averaged across all brain regions, indicating an overall improvement in white matter integrity. +4 more findings

  19. 2025-07-01

    Mind your nose: A randomized controlled trial of olfactory‐based memory training for older people with subjective cognitive decline

    ✓ Peer-reviewed Prevention trials Alzheimer s & Dementia Translational Research & Clinical Interventions

    Key finding: Consistent with previous research, transfer gains from the OMT condition to an untrained VM task suggest that olfaction may contribute to a‐modal representations of memory. +2 more findings

  20. 2025-07-01

    Profiling complement dysregulation in frontotemporal dementia using cerebrospinal fluid, plasma, and exosomes

    ✓ Peer-reviewed Disease mechanisms Immunobiology

    Key finding: In plasma, most complement analytes were not significantly different between spFTD and HC; the exceptions were C4 and FB, significantly decreased in spFTD vs HC ( p = 0.0192 and p = 0.0181, respectively), suggesting complement consumption in classical and alternative pathways. +2 more findings

  21. 2025-07-01

    C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disorders

    ✓ Peer-reviewed Disease mechanisms Immunobiology

    Key finding: Compared to HC, C3, C3a and properdin were elevated in FTLD (p = 0.0002, p = 0.0187, p = 0.0451 respectively). +4 more findings

  22. 2025-07-01
  23. 2025-07-01

    Paeoniflorin exercise-mimetic potential regulates the Nrf2/HO-1/BDNF/CREB and APP/BACE-1/NF-κB/MAPK signaling pathways to reduce cognitive impairments and neuroinflammation in amnesic mouse model

    ✓ Peer-reviewed Inflammation and the immune system Biomedicine & Pharmacotherapy

    Key finding: Microglia-mediated neuroinflammation plays a crucial role in memory and cognitive deficits and the development of early mild cognitive impairment (MCI) associated with Alzheimer's disease (AD). +2 more findings

  24. 2025-07-01

    Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis

    ✓ Peer-reviewed Inflammation and the immune system Nature Communications

    Key finding: In the APPswe/PS1dE9 (APP/PS1) mouse model of amyloidosis, we demonstrated that microglial Cx43 hemichannels correlated with microglial malfunction, which in turn exacerbated β-amyloid pathology.

  25. 2025-07-01

    Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer's disease: a longitudinal cohort study

    ✓ Peer-reviewed Brain tissue and pathology EBioMedicine

    Key finding: Longitudinal analysis identified significant associations between the change in ether lipid species (including alkylphosphatidylcholine, alkenylphosphatidylcholine, lysoalkylphosphatidylcholine, and lysoalkenylphosphatidylcholine) and AD dementia conversion. +4 more findings

Browse the library by subject, with the full score breakdown →